FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely oncology, and can be used for screening of probability of presence of colorectal cancer. Disclosed is a method comprising measuring the level of biomarkers in a biological fluid sample obtained from a subject: ApoA2, B2M, CYFRA.21.1, Ddimer, HE4, hsCRP, TTR, CEA, sVCAM.1, ApoA1, CA19.9, CA125, with subsequent treatment of a set of derived values of biomarkers using at least one classification model trained to determine high or low probability of having colorectal cancer.
EFFECT: invention provides higher accuracy of the method for determining the probability of having colorectal cancer in European population.
4 cl, 9 dwg, 4 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR EARLY DIAGNOSIS OF LUNG CANCER | 2018 |
|
RU2697971C1 |
| METHOD FOR SCREENING PROBABILITY OF BREAST CANCER PRESENCE | 2019 |
|
RU2718272C1 |
| METHOD FOR SCREENING PROBABILITY OF BLADDER CANCER | 2019 |
|
RU2718284C1 |
| METHOD FOR SCREENING PROBABILITY OF KIDNEY CANCER | 2023 |
|
RU2816798C1 |
| METHOD OF APPLYING INFORMATION ON A COMPLEX GROUP OF BIOMARKERS FOR DIAGNOSING A MALIGNANT LUNG TUMOR IN SUBJECT, DIAGNOSTIC KIT AND COMPUTER SYSTEM USING IT | 2017 |
|
RU2687578C2 |
| METHOD FOR DIAGNOSTICS OF LUNG CANCER | 2021 |
|
RU2784356C1 |
| METHOD FOR DIAGNOSING COLORECTAL CANCER | 2023 |
|
RU2819181C1 |
| SCREENING METHOD OF COLORECTAL CANCER DIAGNOSING | 2021 |
|
RU2798058C2 |
| METHOD FOR DETERMINING PROBABILITY OF PRESENCE OF CARDIOVASCULAR DISEASE | 2023 |
|
RU2829792C2 |
| METHOD OF NON-INVASIVE DIAGNOSIS OF BLADDER CANCER BASED ON DETECTION OF TUMOR DNA IN BIOLOGICAL FLUIDS AND SET OF REAGENTS FOR ITS IMPLEMENTATION | 2023 |
|
RU2813669C1 |
